RECENTLY ADDED PODCASTS
Dr. Toney reviews the epidemiology and management of Varicella Zoster infections. He first discusses the prevalence and clinical presentation of this herpesvirus family infection. He points out the importance of recognizing the prodrome in patients before the complete outbreak occurs. He goes on to discuss the clinical complications of VZV disease, including ophthalmologic, multi-dermatomal, and disseminated infections. He next discusses the treatment options available to manage Zoster infections. The subject of available Zoster vaccines is then discussed, with a focus on the newer Recombinant Zoster Vaccine (RZV). Lastly, Dr. Toney presents a couple of photo case-studies.
In this update recorded in November, 2019, originally for Florida providers, Dr. Baluch reviews Hepatitis A, B, and C. She includes information on Hepatitis C treatment and includes several valuable takeaway points.
Dr. Baluch provides an overview of how to structure an infection control program for a hospital. She reviews the different types of infection control precautions (standard, contact, droplet, special, airborne). She also addresses specific situations such as with measles and with stem cell transplant patients and other immunocompromised individuals.
Dr. Shewayish shows how public health is an essential component of economic prosperity. This is at no time more a poignant argument than in the midst of the current pandemic, where it is clear that the key to economic recovery is to vanquish the coronavirus outbreak. As we have seen in the Spring and early Summer of 2020, infectious diseases can affect a large swath of the business sector, from agriculture, to manufacturing, transportation, hospitality/travel, and many others. Some industries may have a business model that is incompatible with an infection outbreak. Others may ride the wave of increased demand that occurs as a result of the disease’s impact on society. A disease outbreak may also cause individuals to withdraw from the economy due to fear, job loss, or reduced services. Investing in public health is an endeavor that pays countless dividends. As the pandemic shows, societies around the world need to do more to invest in the health of their populations and in preparing for the next outbreak that may impact us.
By Greg Teo, MD
Dr. Teo presents a thorough review of the currently available treatment options for COVID-19 disease. He begins by summarizing the evidence for available antiviral treatment options. Next, he discusses the available data for several pharmacologic support therapies currently under investigation. Lastly, he presents the NIH and/or IDSA recommendations regarding those therapies. Therapies discussed include hydroxychloroquine, remdesivir, HIV protease inhibitor, Favipiravir, Tocilizumab, interferons, and others. Dr. Teo also looks at convalescent plasma and its promising role in certain patients with severe COVID-19.
Dr. Horn reviews several important tropical diseases, including Chagas disease (caused by Trypanosoma cruzii), spread by the Triatomid bug, African Trypanosomiasis, the cause of sleeping sickness, Cystercercosis, caused by the Pork tapeworm, and Buruli ulcer. He closes by discussing Onchocerciasis and its effect on significant areas of the developing world.
Dr. Velez compares and contrasts the two pandemics capping the last one-hundred years. She presents an in-detail look at the 1918 Influenza pandemic with a focus on its history and epidemiology. She then contrasts the current COVID-19 pandemic and concludes by comparing both in a thoughtful and insightful manner.
With the help of the popular online web site Snopes.com, and a hint of inspiration from the “Mythbusters,” Dr Oehler reviews contemporary myths and online conspiracy theories about COVID-19 and the SARS 2 Coronavirus. The author tackles such myths as whether government statistics about coronavirus deaths are accurate, predictions that the pandemic would occur in 2020, and whether coronavirus can be transmitted through packages, food, and pets. Dr. Oehler concludes by looking at one of the most enduring of COVID-19 questions. Did the virus originate in a bioweapons lab or in nature?